Plasma miRNAs might be promising biomarkers of chronic obstructive pulmonary disease

Clinical Respiratory Journal

Volumn 10, Issue 1, 2016, Pages 104-111

  Wang, Maoyun ^a,b   Huang, Yuchuan ^a,b   Liang, Zong'an ^a,b   Liu, Dan ^a,b   Lu, Yanrong ^a,b   Dai, Ya ^a,b   Feng, Guanglin ^a,b   Wang, Changguo ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b Chuanyu Branch of China Tobacco Corporation   (China)

Author keywords

Biomarkers; COPD; Plasma miRNAs; Smoking

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 1229 3P; MICRORNA 145 5P; MICRORNA 338 3P; MICRORNA 3620 3P; MICRORNA 4485; MICRORNA 4707 3P; MICRORNA 636; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOWN REGULATION; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; MALE; MIDDLE AGED; PRIORITY JOURNAL; RNA ANALYSIS; SMOKING; UPREGULATION; ADVERSE EFFECTS; AGED; BLOOD; GENETICS;

AGED; BIOMARKERS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84953710282     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12194     Document Type: Article

References (38)

1. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998;4: 1241-1243.
2. Celli BR, Cote CG, Marin JM, etal. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350: 1005-1012.
3. Ambros V. microRNAs: tiny regulators with great potential. Cell. 2001;107: 823-826.
4. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27: 5848-5856.
5. Latronico MVG, Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol. 2009;6: 418-429.
6. Cuellar TL, McManus MT. MicroRNAs and endocrine biology. J Endocrinol. 2005;187: 327-332.
7. Mehler MF, Mattick JS. Non-coding RNAs in the nervous system. J Physiol. 2006;575: 333-341.
8. Liang Y, Ridzon D, Wong L, etal. Characterization of microRNA expression 433 profiles in normal human tissues. BMC Genomics. 2005;8: 166.
9. Van Pottelberge GR, Mestdagh P, Brachke KR, etal. microRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183: 898-906.
10. Leidinger P, Keller A, Borries A, etal. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer. 2011;74: 41-47.
11. Sessa R, Hata A. Role of microRNAs in lung development and pulmonary diseases. Pulm Circ. 2013;3(2): 315-328.
12. Huang YC, Dai Y, Zhang J, etal. Circulating microRNAs as potential biomarkers for smoking-related interstitial fibrosis. Biomarkers. 2012;17: 435-440.
13. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ. 1977;1: 1645-1648.
14. Takahashi K, Yokota S, Tatsumi N, etal. Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects. Toxicol Appl Pharmacol. 2013;272: 154-160.
15. Barnes PJ, Kleinert S. COPD - a neglected disease. Lancet. 2004;364(9434): 564-565.
16. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011. [homepage on the Internet]. Available at: http://www.goldcopd.org/ (accessed 20 August 2013).
17. Jackson H, Hubbard R. Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey. BMJ. 2003;327(7416): 653-654.
18. Walters JA, Walters EH, Nelson M, etal. Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J. 2011;20(4): 396-402.
19. Averame G, Bonavia M, Ferri P, etal. Office spirometry can improve the diagnosis of obstructive airway disease in primary care setting. Respir Med. 2009;103(6): 866-872.
20. Buffels J, Degryse J, Liistro G, Decramer M. Differential diagnosis in a primary care population with presumed airway obstruction: a real-life study. Respiration. 2012;84(1): 44-54.
21. Garofalo M, Romano G, Di Leva G, etal. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med. 2012;18: 74-82.
22. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6: 857-866.
23. Hassan T, McKiernan PJ, McElvaney NG, Cryan SA, Greene CM. Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases. Expert Rev Anti Infect Ther. 2012;10: 359-368.
24. Kumar P, Dezso Z, Mackenzie C, etal. Circulating miRNA biomarkers for Alzheimeris disease. PLoS ONE. 2013;8(7): e69807.
25. Zhang X, Guo J, Fan S, etal. Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis. PLoS ONE. 2013;8(12): e81076.
26. Zhao H, Shen J, Medico L, etal. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS ONE. 2010;5(10): e13735.
27. Zhang X, Guo J, Fan SF, etal. Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagenosis. PLoS ONE. 2013;8(12): e81076.
28. Akao Y, Iio A, Itoh T, etal. Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol Ther. 2011;19: 395-399.
29. Chen X, Liang H, Zhang J, Zen K, Zhang C-Y. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. 2012;22: 125-132.
30. Hunter MP, Ismail N, Zhang X, etal. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE. 2008;3: e3694.
31. Zernecke A, Bidzhekov K, Noels H, etal. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009;2: ra81.
32. Mitchell PS, Parkin RK, Kroh EM, etal. Circulating microRNAs as stable blood-based markers for cancer detection. PNAS. 2008;105: 10513-10518.
33. Frieri M. Advances in the understanding of allergic asthma. Allergy Asthma Proc. 2007;28: 614-619.
34. Collison A, Mattes J, Plank M, Foster PS. Inhibition of house dust mite induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol. 2011;128: 160-167, e4.
35. Zhang Y, Zhang M, Zhong M, etal. Expression profiles of miRNAs in polarized macrophages. Int J Mol Med. 2013;31(4): 797-802.
36. Li C, Bai Y, Liu H, etal. Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs. Acta Biochim Biophys Sin (Shanghai). 2013;45(8): 692-699.
37. Kos A, Olde Loohuis NF, Wieczorek ML, etal. A potential regulatory role for intronic microRNA-338-3p for its host gene encoding apoptosis-associated tyrosine kinase. PLoS ONE. 2012;7(2): e31022.
38. Christenson SA, Schembri FM, Sridhar S, etal. Impact of smoking on miRNA expression in buccal and nasal epithelium. Am J Respir Crit Care Med. 2009;179: 457-466.